Alectinib Drug as Therapy for Advanced Lung Cancer
Advanced non-small cell lung cancer is one of the most common types of lung cancer. Lung cancer occurs when the cells of the lung become abnormal and begin to grow uncontrollably. Alectinib drug could replace crizotinib drug as a first-line of care in treating advanced ALK-positive non-small cell lung cancer.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer